231 related articles for article (PubMed ID: 23349893)
1. HIV-1 fusion is blocked through binding of GB Virus C E2-derived peptides to the HIV-1 gp41 disulfide loop [corrected].
Eissmann K; Mueller S; Sticht H; Jung S; Zou P; Jiang S; Gross A; Eichler J; Fleckenstein B; Reil H
PLoS One; 2013; 8(1):e54452. PubMed ID: 23349893
[TBL] [Abstract][Full Text] [Related]
2. GB virus type C interactions with HIV: the role of envelope glycoproteins.
Mohr EL; Stapleton JT
J Viral Hepat; 2009 Nov; 16(11):757-68. PubMed ID: 19758271
[TBL] [Abstract][Full Text] [Related]
3. Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.
Koedel Y; Eissmann K; Wend H; Fleckenstein B; Reil H
J Virol; 2011 Jul; 85(14):7037-47. PubMed ID: 21543477
[TBL] [Abstract][Full Text] [Related]
4. GB virus type C E2 protein inhibits human immunodeficiency virus type 1 assembly through interference with HIV-1 gag plasma membrane targeting.
Timmons CL; Shao Q; Wang C; Liu L; Liu H; Dong X; Liu B
J Infect Dis; 2013 Apr; 207(7):1171-80. PubMed ID: 23303812
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
Maerz AL; Drummer HE; Wilson KA; Poumbourios P
J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
[TBL] [Abstract][Full Text] [Related]
6. Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide.
Herrera E; Gomara MJ; Mazzini S; Ragg E; Haro I
J Phys Chem B; 2009 May; 113(20):7383-91. PubMed ID: 19402654
[TBL] [Abstract][Full Text] [Related]
7. Study of the inhibition capacity of an 18-mer peptide domain of GBV-C virus on gp41-FP HIV-1 activity.
Haro I; Gómara MJ; Galatola R; Domènech O; Prat J; Girona V; Busquets MA
Biochim Biophys Acta; 2011 Jun; 1808(6):1567-73. PubMed ID: 21377446
[TBL] [Abstract][Full Text] [Related]
8. Chimpanzee GB virus C and GB virus A E2 envelope glycoproteins contain a peptide motif that inhibits human immunodeficiency virus type 1 replication in human CD4⁺ T-cells.
McLinden JH; Stapleton JT; Klinzman D; Murthy KK; Chang Q; Kaufman TM; Bhattarai N; Xiang J
J Gen Virol; 2013 Apr; 94(Pt 4):774-782. PubMed ID: 23288422
[TBL] [Abstract][Full Text] [Related]
9. Synthetic peptides derived from an N-terminal domain of the E2 protein of GB virus C in the study of GBV-C/HIV-1 co-infection.
Fernández L; Chan WC; Egido M; Gómara MJ; Haro I
J Pept Sci; 2012 May; 18(5):326-35. PubMed ID: 22438139
[TBL] [Abstract][Full Text] [Related]
10. Modification of FP-HIV activity by peptide sequences of GB virus C: a biophysical approach.
Domènech O; Ortiz A; Pujol M; Haro I; Muñoz M; Alsina MA; Prat J; Busquets MA; Girona V
Biochim Biophys Acta; 2014 May; 1838(5):1274-80. PubMed ID: 24530897
[TBL] [Abstract][Full Text] [Related]
11. Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120.
Liu S; Lu H; Niu J; Xu Y; Wu S; Jiang S
J Biol Chem; 2005 Mar; 280(12):11259-73. PubMed ID: 15640162
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication.
Xiang J; McLinden JH; Kaufman TM; Mohr EL; Bhattarai N; Chang Q; Stapleton JT
Virology; 2012 Aug; 430(1):53-62. PubMed ID: 22608061
[TBL] [Abstract][Full Text] [Related]
13. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor.
Derdeyn CA; Decker JM; Sfakianos JN; Zhang Z; O'Brien WA; Ratner L; Shaw GM; Hunter E
J Virol; 2001 Sep; 75(18):8605-14. PubMed ID: 11507206
[TBL] [Abstract][Full Text] [Related]
15. Peptide mimic of the HIV envelope gp120-gp41 interface.
Kim S; Pang HB; Kay MS
J Mol Biol; 2008 Feb; 376(3):786-97. PubMed ID: 18178220
[TBL] [Abstract][Full Text] [Related]
16. GB virus C particles inhibit T cell activation via envelope E2 protein-mediated inhibition of TCR signaling.
Bhattarai N; McLinden JH; Xiang J; Landay AL; Chivero ET; Stapleton JT
J Immunol; 2013 Jun; 190(12):6351-9. PubMed ID: 23686495
[TBL] [Abstract][Full Text] [Related]
17. Lineage-specific differences between human and simian immunodeficiency virus regulation of gp120 trimer association and CD4 binding.
Finzi A; Pacheco B; Xiang SH; Pancera M; Herschhorn A; Wang L; Zeng X; Desormeaux A; Kwong PD; Sodroski J
J Virol; 2012 Sep; 86(17):8974-86. PubMed ID: 22696649
[TBL] [Abstract][Full Text] [Related]
18. CD4 activation of HIV fusion.
Sattentau QJ
Int J Cell Cloning; 1992 Nov; 10(6):323-32. PubMed ID: 1281202
[TBL] [Abstract][Full Text] [Related]
19. The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.
Lu W; Chen S; Yu J; Behrens R; Wiggins J; Sherer N; Liu SL; Xiong Y; Xiang SH; Wu L
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651369
[TBL] [Abstract][Full Text] [Related]
20. Efficient Fusion at Neutral pH by Human Immunodeficiency Virus gp41 Trimers Containing the Fusion Peptide and Transmembrane Domains.
Liang S; Ratnayake PU; Keinath C; Jia L; Wolfe R; Ranaweera A; Weliky DP
Biochemistry; 2018 Feb; 57(7):1219-1235. PubMed ID: 29345922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
